XML 19 R6.htm IDEA: XBRL DOCUMENT v3.20.2
STATEMENT OF CONSOLIDATED CASH FLOWS - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash Flows From Operating Activities    
Net income (loss) $ (2,629) $ 109
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
(Gains) losses on asset sales, net (8) (22)
Depreciation, depletion and amortization 1,070 992
Impairment 2,126 0
Exploratory dry hole costs 135 0
Exploration lease and other impairment 38 11
Stock compensation expense 47 48
Noncash (gains) losses on commodity derivatives, net 119 58
Provision (benefit) for deferred income taxes and other tax accruals (95) (1)
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable 628 (70)
(Increase) decrease in inventories (99) (33)
Increase (decrease) in accounts payable and accrued liabilities (520) (130)
Increase (decrease) in taxes payable (63) 14
Changes in other operating assets and liabilities (38) (63)
Net cash provided by (used in) operating activities 711 913
Cash Flows From Investing Activities    
Additions to property, plant and equipment - E&P (1,250) (1,085)
Additions to property, plant and equipment - Midstream (147) (210)
Payments for Midstream equity investments 0 (23)
Proceeds from asset sales, net of cash sold 11 22
Other, net (2) (1)
Net cash provided by (used in) investing activities (1,388) (1,297)
Cash Flows From Financing Activities    
Net borrowings (repayments) of debt with maturities of 90 days or less 72 160
Debt with maturities of greater than 90 days – Borrowings 1,000 0
Debt with maturities of greater than 90 days - Repayments 0 (5)
Payments on finance lease obligations (3) (45)
Common stock acquired and retired 0 (25)
Cash dividends paid (157) (164)
Noncontrolling interests, net (128) (27)
Other, net (6) 4
Net cash provided by (used in) financing activities 778 (102)
Net Increase (Decrease) in Cash and Cash Equivalents 101 (486)
Cash and Cash Equivalents at Beginning of Year 1,545 2,694
Cash and Cash Equivalents at End of Period $ 1,646 $ 2,208